3D Systems: Looking Beyond The Short-Term Pain

3D Systems – making huge strides in the healthcare business. In fact, revenue from healthcare was up 46% in the previous quarter, driven by an expansion of the user base and product adoption.  This acquisition has added virtual surgical planning, guiding, and 3D printing of medical devices to 3D Systems’ portfolio.

Source: seekingalpha.com

Drug testing is what empties the pockets of many of the pharmaceutical companies out there. Each year, over $40 billion is spent on clinical trials in the United States alone. Companies like Organovo are working on 3D future-3printing human tissue, which in the short run will allow pharmaceutical companies to test their drugs on human cells without a risk to human beings.